Informations générales (source: ClinicalTrials.gov)
Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR
Observational
Hospices Civils de Lyon (Voir sur ClinicalTrials)
janvier 2018
décembre 2023
05 avril 2025
The aim of this study is to determine if delta-haemolysin production deficiency of
Staphylococcus aureus is a marker in favour of chronic infections on implants
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Hospices Civils de Lyon - 69004 - Lyon - France | Eugenie Mabrut, CRA | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- patients having implant infection due to S. aureus treated by DAIR
- patients having implant infection due to S. aureus treated by DAIR
- none